As of May 10, 2025, SYNLAB (SYAB.DE) has a market cap of $2.73 billion USD. According to our data, SYNLAB is ranked No. in global market value.
Year | Market Cap | %Change |
---|---|---|
Jul 12, 2024 | $2.73 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$659.45 B |
0.031 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$371.06 B |
-0.010 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$326.55 B |
-0.015 M
|
![]() USA
|
![]() Novo Nordisk A/S
NOVO-B.CO
|
$297.81 B |
72.041 B
|
![]() Denmark
|
![]() Novo Nordisk
NVO
|
$296.96 B |
75.418 B
|
![]() Denmark
|
![]() Roche
ROG.SW
|
$249.13 B |
35.619 B
|
![]() Switzerland
|
![]() Novartis
NVS
|
$215.79 B |
1.101 B
|
![]() Switzerland
|
![]() AstraZeneca
AZN
|
$209.49 B |
0.000 M
|
![]() UK
|
![]() Merck
MRK
|
$190.76 B |
0.005 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$152.18 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$142.95 B |
0.007 M
|
![]() USA
|
![]() Sanofi
SNY
|
$126.84 B |
4.813 B
|
![]() France
|
![]() Pfizer
PFE
|
$126.67 B |
0.001 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$120.65 B |
-0.001 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$109.14 B |
-0.001 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$94.53 B |
-0.002 M
|
![]() USA
|
![]() Chugai Pharmaceutical
4519.T
|
$93.07 B |
-0.001 M
|
![]() Japan
|
![]() GlaxoSmithKline
GSK
|
$74.41 B |
0.004 M
|
![]() UK
|
![]() CSL
CSL.AX
|
$74.32 B |
0.001 M
|
![]() Australia
|
![]() Zoetis
ZTS
|
$70.91 B |
0.001 M
|
![]() USA
|
Market Cap | = | SYAB.DE Stock Price | * | SYAB.DE Shares Outstanding |
= | $0.00 | * | 0.22 B | |
= | $2.73 B |